Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-75
SponsorTanta University
About this trial
The aim of the study is to compare between the role of dapagliflozin versus dexamethasone in pre-operative management of non-diabetic glioma patients on levetiracetam as anti-seizure drug.
Eligibility criteria
Qualifiers
Males & females.
Age: between 18 and 75 years old.
The initial clinical examination.
Magnetic resonance imaging of the brain (MRI) with contrast.
Disqualifiers
Age: > 75 years old, and <18 years old.
Breast feeding female. • Pregnant female.
eGFR< 30 mL/minute/1.73 m2.
Patients with diabetes mellitus.
Trial design
Treatments tested in this trial
- Dapagliflozin placebo
- Placebo
- DexamethasoneGroup III (n=25) (Dexamethasone group)
Treatment groups
75 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov